Arcutis Biotherapeutics (ARQT) Profit After Tax: 2021-2025
Historic Profit After Tax for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Sep 2025 value amounting to $7.4 million.
- Arcutis Biotherapeutics' Profit After Tax rose 117.84% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$44.3 million, marking a year-over-year increase of 77.33%. This contributed to the annual value of -$140.0 million for FY2024, which is 46.58% up from last year.
- Latest data reveals that Arcutis Biotherapeutics reported Profit After Tax of $7.4 million as of Q3 2025, which was up 146.64% from -$15.9 million recorded in Q2 2025.
- Arcutis Biotherapeutics' Profit After Tax's 5-year high stood at $7.4 million during Q3 2025, with a 5-year trough of -$107.7 million in Q3 2022.
- In the last 3 years, Arcutis Biotherapeutics' Profit After Tax had a median value of -$41.5 million in 2024 and averaged -$39.6 million.
- In the last 5 years, Arcutis Biotherapeutics' Profit After Tax slumped by 89.03% in 2022 and then surged by 117.84% in 2025.
- Arcutis Biotherapeutics' Profit After Tax (Quarterly) stood at -$71.3 million in 2021, then fell by 0.97% to -$72.0 million in 2022, then climbed by 7.96% to -$66.3 million in 2023, then spiked by 83.72% to -$10.8 million in 2024, then spiked by 117.84% to $7.4 million in 2025.
- Its Profit After Tax stands at $7.4 million for Q3 2025, versus -$15.9 million for Q2 2025 and -$25.1 million for Q1 2025.